PatchSiren cyber security CVE debrief
CVE-2026-15415 AWS CVE debrief
AWS HealthOmics is a HIPAA-eligible service managing infrastructure for bioinformatics analyses. A path traversal issue in the linting tools of the AWS HealthOmics MCP Server before version 0.0.36 might allow an actor to write content to arbitrary locations outside the intended workflow bundle directory. This issue has a CVSS score of 6.8 and a severity of MEDIUM. The vulnerability is caused by improper limitation of a pathname to a restricted directory in the linting tools. Users of AWS HealthOmics MCP Server before version 0.0.36 should be aware of this path traversal vulnerability and take necessary precautions.
- Vendor
- AWS
- Product
- aws-healthomics-mcp-server
- CVSS
- MEDIUM 6.8
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-07-17
- Original CVE updated
- 2026-07-20
- Advisory published
- 2026-07-17
- Advisory updated
- 2026-07-20
Who should care
Users of AWS HealthOmics MCP Server before version 0.0.36 should be aware of this path traversal vulnerability and take necessary precautions. This includes reviewing and monitoring workflow_files input for suspicious activity and implementing compensating controls to restrict write access to sensitive directories. Additionally, users should upgrade to version 0.0.36 or later of the AWS HealthOmics MCP Server.
Technical summary
The AWS HealthOmics MCP Server has a path traversal vulnerability in its linting tools before version 0.0.36. This issue might allow an actor who can influence the MCP agent to write actor-controlled content to arbitrary locations outside the intended workflow bundle directory via directory traversal sequences in the workflow_files input. The vulnerability has a CVSS score of 6.8 and a severity of MEDIUM. The issue is caused by improper limitation of a pathname to a restricted directory in the linting tools.
Defensive priority
Medium priority due to the potential for arbitrary content writing.
Recommended defensive actions
- Upgrade to version 0.0.36 or later of the AWS HealthOmics MCP Server
- Review and monitor workflow_files input for suspicious activity
- Implement compensating controls to restrict write access to sensitive directories
- Review the official advisory for more information
- Verify the affected scope and severity with the official advisory
- Track exceptions and retest remediated assets
Evidence notes
The CVE record was published on 2026-07-17T20:17:15.923Z and has not been modified since then. The NVD entry is currently 6.8 MEDIUM. There is limited information available about the vulnerability, and defenders should verify the affected scope and severity with the official advisory. The AWS HealthOmics MCP Server before version 0.0.36 has a path traversal vulnerability in its linting tools, which might allow an actor to write content to arbitrary locations outside the intended workflow bundle directory. Users should review the official advisory for more information and upgrade to version 0.0.36 or later.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-15415 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-15415
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-15415 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-15415
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://aws.amazon.com/security/security-bulletins/2026-060-aws/
ff89ba41-3aa1-4d27-914a-91399e9639e5
-
Source reference
Unverified legacy reference
URL: https://github.com/awslabs/mcp/security/advisories/GHSA-6x7f-488g-75wm
ff89ba41-3aa1-4d27-914a-91399e9639e5
-
Source reference
Unverified legacy reference
URL: https://pypi.org/project/awslabs.aws-healthomics-mcp-server/0.0.36/
ff89ba41-3aa1-4d27-914a-91399e9639e5
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.